Home / Import refusals / DSV-0217956-9/11/1

FDA Import Refusal DSV-0217956-9/11/1 — Xellia Pharmaceuticals ApS

Xellia Pharmaceuticals ApS — FEI 3002806860

The FDA refused shipment DSV-0217956-9/11/1 from Xellia Pharmaceuticals ApS (Denmark) on July 27, 2018. The refused product falls under Drugs and Biologics — VANCOMYCIN HYDROCHLORIDE. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
July 27, 2018
Country
Denmark
Product Category
Drugs and Biologics
Product Code
56KCS85 VANCOMYCIN HYDROCHLORIDE
Charges
75

Recent inspections

  • 1244910 (VAI Thu Oct 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1123814 (VAI Fri Oct 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1051572 (VAI Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 975111 (VAI Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 880296 (VAI Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 739-7034304-9/1/1 (Thu Aug 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • M21-0750389-0/1/1 (Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • W47-0058431-7/1/1 (Wed Feb 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 845-2025074-1/1/1 (Mon Oct 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 845-2021672-6/6/1 (Wed Feb 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources